DxS has had its TheraScreen: K-RAS Mutation Kit granted a licence by the regulatory body Health Canada for use as a diagnostic for anti-EGFR therapies and as the companion diagnostic for Amgens colorectal cancer therapy, Vectibix.
Read More
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MorePrometheus Laboratories Inc has announced the launch of MyCeliacID, the first do it yourself, saliva-based genetic test dedicated to celiac disease.
Read MoreOxford Gene Technology (OGT) announces that the Center for Human Genetics at Katholieke Universiteit Leuven, Belgium, has begun assessment of its CytoSure arrays for use in prenatal diagnostic research.
Read More
Crucial details are yet to come, but billions in health care dollars will likely affect clinical laboratories in ways both direct and indirect.
Read More